Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Hebert

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Neuro-Oncology|August 1, 1993
Multiple fraction-per-day radiotherapy for patients with brain stem tumorsM E Hebert, E C Halperin, W J Oakes, et al.
The Annals of Pharmacotherapy|March 1, 1995
Anaphylactoid reactions with intraperitoneal cisplatinM E Hebert, J L Blivin, J Kessler, et al.
American Journal of Clinical Oncology|August 1, 1996
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findingsM E Hebert, V J Lowe, J M Hoffman, et al.
Leukemia|August 1, 1993
Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia modelL C Gravatt, S Chaffee, M E Hebert, et al.
Head & Neck|November 24, 1999
Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancersD L Carter, M E Hebert, K Smink, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1994
To treat or not to treat the internal mammary nodes: a possible compromiseL B Marks, M E Hebert, G Bentel, et al.
Transplantation|October 1, 1991
Pharmacologic purging of malignant T cells from human bone marrow using 9-beta-D-arabinofuranosylguanineM E Hebert, M L Greenberg, S Chaffee, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Neuro-Oncology|August 1, 1993
Multiple fraction-per-day radiotherapy for patients with brain stem tumorsM E Hebert, E C Halperin, W J Oakes, et al.
The Annals of Pharmacotherapy|March 1, 1995
Anaphylactoid reactions with intraperitoneal cisplatinM E Hebert, J L Blivin, J Kessler, et al.
American Journal of Clinical Oncology|August 1, 1996
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findingsM E Hebert, V J Lowe, J M Hoffman, et al.
Leukemia|August 1, 1993
Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia modelL C Gravatt, S Chaffee, M E Hebert, et al.
Head & Neck|November 24, 1999
Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancersD L Carter, M E Hebert, K Smink, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1994
To treat or not to treat the internal mammary nodes: a possible compromiseL B Marks, M E Hebert, G Bentel, et al.
Transplantation|October 1, 1991
Pharmacologic purging of malignant T cells from human bone marrow using 9-beta-D-arabinofuranosylguanineM E Hebert, M L Greenberg, S Chaffee, et al.
Pageof 1